Genfit SA
Save
–
Market cap
–
Current P/E
5.06x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Genfit S. A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis.
Similar securities
Based on sector and market capitalization
Report issue